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Material and Methods: Between 2013 and 2015 seven pts, 5 
males and 2 females, median age 77 yrs (range: 35-85 yrs) 
received SBRT for primary or metastatic thoracic tumors: 4 
primary lung cancer, 2 mediastinal lymphnode metastasis, 1 
lung metastasis. All pts had a 4D-CT high-resolution 
simulation in 10 respiratory phases for ITV definition. GTV 
and ITV volumes were 4.5-21.4 cm3 and 6.8-39.4 cm3, 
respectively. ITV-PTV margins were 5 mm (median), range: 3-
5 mm. All pts were treated by IG-IMRT volumetric modulated 
arc therapy with 2 modulated arcs. Doses were prescribed 
according to ICRU 83 (median PTV dose) and 99% of PTV had 
to be encompassed by 90% isodose. Total doses were: 20 Gy x 
3 in 1 pt, 12 Gy x 4 in 1 pt, 10 Gy x 5 in 1 pt, 7.5 Gy x 8 in 1 
pt, 6 Gy x 8 in 3 pts. Before CBCT acquisition in all pts 2 
planar (AP-LL) set-up EPID images (kV/MV) were taken for 
preliminary set-up analysis. In absence of rotations on EPID 
imaging, CBCT images (Nr.=44) were acquired for on-line set-
up corrections which were applied before of each 1st SBRT 
treatment arc. Intra-fraction motion was evaluated by 
further CBCT images acquired before starting and at the end 
of the 2nd treatment arc. Structure matching on CBCT was 
automatically done first on bone and then on soft tissue. In-
room mean elapsed time between 1st and last CBCT was 26 
min (range:11-47 min). On-line set-up corrections between 
1st and 2nd arc were applied for errors of ≥ 3mm. For the 
whole series of 7 pts mean differences between planned and 
shifted ITV position along the 3 spatial axes (CC, AP, LL) were 
then calculated on 57 CBCT images, 35 taken between 1st 
and 2nd arc, 22 at the end of 2nd arc. For each patient 
isodose distribution was recalculated on the TPS after 
correction of the isocenter position of the 2 arcs applying the 
mean differences found. Finally, differences in ITV median 
dose, V90, V95, and D98 were calculated. 
 
Results: Mean ITV displacements after the 1st arc were 1.2 
mm ± 1.6 mm, 0.5 mm ± 1.4 mm, 0 mm ± 1.1 mm for CC, AP 
and LL directions, respectively. Mean displacements at the 
end of 2nd arc were 0.1 mm ± 1.4 mm, 0.7 mm ± 1.0 mm, 0.3 
mm ± 0.9 mm for CC, AP and LL directions, respectively. 
Differences between planned and delivered ITV median dose 
ranged from -0.2% to -1.8%; V90 was ≥ 99.8% in all pts, V95 
range was 86.7%-99.7%; D98 was ≥ 92.7% in all pts (Fig. 1). 
 
 
 
Conclusion: Our preliminary analysis of 101 CBCT in 7 pts 
aimed at evaluating intra-fraction organ motion during V-MAT 
SBRT of thoracic targets shows that ITV dosimetric coverage 
is only minimally influenced by intra-fraction ITV 
displacement, provided that on-line corrections are applied 
before each treatment arc. Our findings need to be 
prospectively confirmed in a larger patient series. 
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Purpose or Objective: The inclusion of the Internal Mammary 
Nodes (IMNs) in managing left sided post-mastectomy 
radiotherapy (PMRT) patients has a potential benefit in 
patient outcomes and disease control. Larger treatment 
fields result in higher doses to normal tissue but advancing 
technological techniques, such as the use of Active Breath 
Control (ABC) mean acceptable dose parameters may be 
achieved.  
 
Material and Methods: 50 randomly selected patients with 
left sided breast cancer receiving PMRT underwent CT 
simulation with and without ABC, 100 radiotherapy (RT) plans 
were generated. 30 additional patients requiring left sided 
PMRT with free-breathing (FB) CT simulation scan were 
selected at random as a control group. The IMNs were 
delineated as a target volume within the first 3 intercostal 
spaces as were organs at risk (OAR)- left anterior descending 
coronary artery (LADCA), heart, lung and contralateral breast 
(CB). Modified wide-tangent photon fields, with the inclusion 
of chest wall, IMNs, axilla and supraclavicular fossa as a 4-
field technique were generated for all 130 plans. Statistical 
analysis was completed using Wilcoxon Signed Rank test, 
Mann Whitney test and Pearson and Spearman Correlation 
Coefficients. 
 
Results: IMN PTV coverage in plans with ABC was reduced 
compared to FB (94 vs 98% p<0.001), meeting dosimetric 
criteria for coverage in 90% of plans (range 79-100%). ABC 
significantly reduced dose to all OARs compared to FB - 
median reduction in mean heart dose (MHD) (6.3Gy vs 1.9Gy 
p<0.001), lung V20 (15% vs 11% p<0.001), LADCA max dose to 
0.2cc (49Gy vs 17.8Gy p<0.001) and LADCA mean dose (40Gy 
vs 10Gy p<0.001), with no difference in the D5 to the CB 
(2.2Gy vs 2.1Gy p=0.36).  
In the control vs ABC group, there was no difference in IMN 
PTV coverage (median 94.5% vs 96% p=0.21). There was 
significant median reduction in MHD (3.5Gy vs 1.9Gy 
p<0.001), lung V20 (14% vs 11% p<0.001), LADCA maximum 
dose to 0.2cc (43.9Gy vs 17.8Gy p<0.001) and LADCA mean 
dose (22.6Gy vs 10Gy p<0.001) for the ABC group, but an 
increase in D5 to the CB with the use of ABC (1.5Gy vs 2.1Gy 
p<0.001). 
BMI was not directly correlated with IMN PTV coverage, or 
increase/decrease in OAR constraints.  
 
Conclusion: Our data supports the standard use of ABC in left 
sided PMRT patients that require the inclusion of the IMNs. 
We have demonstrated adequate IMN PTV coverage with 
significant sparing of OARs. The impact of these dosimetric 
reductions on long-term normal tissue effects requires 
further evaluation in prospective studies. 
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